S-1: Mobix Labs Files for Resale of $62.8 Million in Stock and Warrants After Merger
Registration Statement
Mobix Labs registers for the resale of up to 24,507,435 shares of Class A Common Stock and 3,000,000 warrants by selling securityholders following its merger with Chavant Capital Acquisition Corp.
Summary
- Mobix Labs has filed a registration statement for the potential resale of up to 24,507,435 shares of Class A Common Stock and 3,000,000 warrants by selling securityholders.
- The filing follows Mobix Labs' merger with Chavant Capital Acquisition Corp., which closed on December 21, 2023.
- The registration covers various securities, including consideration shares, earnout shares, equity award shares, legacy warrant shares, PIPE shares, founder shares, advisor shares, and make-whole shares.
- The selling securityholders acquired these securities at prices ranging from approximately $0.00001 to $10.00 per share.
- The company will not receive any proceeds from the sale of these securities by the selling securityholders.
- The company may receive proceeds from the exercise of warrants for cash.
- As of March 28, 2024, the number of shares of Class A Common Stock that may be offered for resale by the Selling Securityholders is approximately 1.29 times larger than the number of outstanding shares of Class A Common Stock.
- The company has also entered into a Purchase Agreement with B. Riley Principal Capital II, which provides the right to sell to B. Riley up to 9,500,000 newly issued shares of Class A Common Stock from time to time over a period of up to 36 months.
Sentiment
Score: 4
Explanation: The document is largely factual, but the potential for significant stock dilution and the lack of immediate proceeds for the company contribute to a slightly negative sentiment.
Positives
- The registration statement allows selling securityholders to potentially realize profits on securities acquired at prices below the current market price.
- The company may receive proceeds from the exercise of warrants for cash, which can be used for working capital and general corporate purposes.
- The Purchase Agreement with B. Riley provides a potential source of capital for the company, although the timing and amount are uncertain.
Negatives
- The company will not receive any proceeds from the sale of securities by the selling securityholders.
- Sales of a substantial number of shares of Class A Common Stock in the public markets, including by the Selling Securityholders, who obtained their shares at prices or values below the current market price, or the perception in the market that such sales could occur, could result in a significant decline in the public trading price of the Class A Common Stock.
- The potential sale of a significant number of shares of Class A Common Stock issuable upon the exercise of warrants, conversion of Class B Common Stock, and settlement of RSUs could further dilute existing shareholders and depress the stock price.
Risks
- Future sales of Class A Common Stock may cause the market price to drop significantly.
- The market price of the company's securities may be volatile.
- An active trading market for the company's Class A Common Stock may not develop.
- The company's management has limited experience in operating a public company.
- The company will require additional capital to fund its operations and growth.
- The company may become subject to securities or class action litigation.
- The company's stockholders will experience dilution in the future.
- The company is an emerging growth company and a smaller reporting company.
- The company does not anticipate paying any cash dividends on its Class A Common Stock in the foreseeable future.
Future Outlook
The company expects to use the net proceeds from the exercise of the Public Warrants, if any, for working capital and general corporate purposes.
Industry Context
The announcement reflects the ongoing activity in the SPAC market, where companies that went public through mergers are now facing the need for further capital and the potential for significant stock dilution as early investors seek to exit their positions.
Comparison to Industry Standards
- The document does not provide enough information to make a detailed comparison to industry standards.
- However, the potential for significant stock dilution is a common concern for companies that went public through SPAC mergers, as early investors often hold a large number of shares acquired at low prices.
- Comparable companies in the semiconductor and communications industries include Microchip Technology, Skyworks Solutions, Analog Devices, and Qualcomm, but their financial situations and stock performance may vary significantly.
Stakeholder Impact
- Existing shareholders may experience dilution and a potential decline in stock price due to the resale of securities by selling securityholders.
- The company may benefit from the exercise of warrants for cash, which can be used for working capital and general corporate purposes.
Next Steps
- The selling securityholders may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices.
- The company will bear all costs, expenses and fees in connection with the registration of the resale of the Offered Securities.
- The Selling Securityholders will bear all commissions and discounts, if any, attributable to their respective sales of the Offered Securities.
Key Dates
| Date | Description |
|---|---|
| July 19, 2021 | Date of Chavants initial public offering (Chavant IPO). |
| November 15, 2022 | Date of the Business Combination Agreement between Chavant and Mobix Labs. |
| December 18, 2023 | Merger approved by the shareholders of Chavant. |
| December 21, 2023 | Closing date of the merger between Chavant and Mobix Labs; Mobix Labs, Inc. name change. |
| December 22, 2023 | Class A Common Stock and Public Warrants began trading on Nasdaq under the symbols MOBX and MOBXW, respectively. |
| January 20, 2024 | Public Warrants become exercisable. |
| January 22, 2024 | Michael Long appointed as a Class III director of the Board. |
| March 18, 2024 | Mobix Labs entered into a Purchase Agreement with B. Riley Principal Capital II. |
| March 28, 2024 | Date used for share outstanding calculations in the document. |
| April 11, 2024 | Last sale price of Class A Common Stock ($2.12) and Public Warrants ($0.2277) reported on Nasdaq. |
Keywords
Class A Common Stock, warrants, resale, registration statement, selling securityholders, merger, Mobix Labs, Chavant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.